Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-010498
Filing Date
2022-05-23
Accepted
2022-05-23 16:17:13
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20220331.htm   iXBRL 10-Q 2241981
2 EX-31.1 meip-ex31_1.htm EX-31.1 18761
3 EX-31.2 meip-ex31_2.htm EX-31.2 18636
4 EX-32.1 meip-ex32_1.htm EX-32.1 13792
5 GRAPHIC img103133933_0.jpg GRAPHIC 34442
  Complete submission text file 0000950170-22-010498.txt   10277926

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20220331_cal.xml EX-101.CAL 36848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20220331_pre.xml EX-101.PRE 370082
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20220331.xsd EX-101.SCH 49145
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20220331_def.xml EX-101.DEF 291741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20220331_lab.xml EX-101.LAB 440109
58 EXTRACTED XBRL INSTANCE DOCUMENT meip-20220331_htm.xml XML 2498205
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 22951810
SIC: 2834 Pharmaceutical Preparations